Skip to main content
. 2022 Apr 1;145:105462. doi: 10.1016/j.compbiomed.2022.105462

Fig. 2.

Fig. 2

The topographical organization of the MEVC-WP, including the adjuvant position, CTL HTL, B cell epitopes, and their respective linkers shown in different colors. The Figure also shows each component epitope utilized in protein-specific candidate vaccine designs (MEVCs,1–7).